A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial

Kobyliak, Nazarii; Abenavoli, Ludovico; Mykhalchyshyn, Galyna; Kononenko, Liudmyla; Boccuto, Luigi; Kyriienko, Dmytro; Dynnyk, Oleh

doi:10.15403/jgld.2014.1121.271.kby

Public

A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial

Published in Journal of Gastrointestinal and Liver Diseases • Mar 9, 2018

Authors:

Nazarii Kobyliak

Ludovico Abenavoli

Galyna Mykhalchyshyn

Abstract

BACKGROUND: Probiotics have a beneficial effect on nonalcoholic fatty liver disease (NAFLD) in animal models. Randomized placebo-controlled trials (RCTs) in NAFLD are still lacking in humans despite a large number of data from animal research. AIM: We performed a double-blind single center RCT of li...

Subject

Medicine

Probiotic

Randomized controlled trial

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!